To our knowledge, this is the first report of a NSV in canine NTRK3. A probably damaging NSV was determined in the CC ERBB2, encoding for HER2, a well-known BC biomarker with diagnostic, prognostic and therapeutic significance. This evidence concerns the gene ERBB2 and breast cancer.